Youlchon Chemical Co.,Ltd.

KRX:008730.KS

29950 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 414,490.61508,944.09538,734.198520,654.57506,617.381489,770.532492,204.661443,482.416436,228.668451,934.965440,653405,702.111376,634.932361,775.664308,500.471278,101.603260,401.589
Cost of Revenue 396,726.624468,918.718485,614.295450,512.881439,925.175433,385.731414,840.869380,161.153375,014.541403,509.543373,892.676348,037.878326,557.481309,005.74257,687.82237,828.549220,771.148
Gross Profit 17,763.98640,025.37253,119.90370,141.68866,692.20556,384.80177,363.79263,321.26261,214.12748,425.42266,760.32457,664.23350,077.45152,769.92450,812.65140,273.05439,630.441
Gross Profit Ratio 0.0430.0790.0990.1350.1320.1150.1570.1430.140.1070.1520.1420.1330.1460.1650.1450.152
Reseach & Development Expenses 7,979.44210,895.13712,069.2134,318.5532,468.4942,167.0242,041.4641,846.8942,438.7742,449.3841,975.6581,881.237851.56935.993621.341484.911647.317
General & Administrative Expenses 3,250.7343,456.7133,311.8963,594.4484,176.7914,328.4034,011.0633,774.2343,516.5823,609.1333,093.7513,127.5743,123.0233,277.6452,806.4252,938.1962,763.064
Selling & Marketing Expenses 10,845.28314,413.6113,745.60515,976.76712,629.16411,673.69512,012.10411,665.73911,930.43911,435.35110,273.4210,125.739,899.1158,674.5538,950.8939,247.5038,343.843
SG&A 26,098.75417,870.32317,057.50119,571.21516,805.95516,002.09816,023.16715,439.97315,447.02115,044.48413,367.17113,253.30413,022.13811,952.19811,757.31812,185.69911,106.907
Other Expenses 113.82415,882.70112,972.77919,532.29321,574.631,456.938749.282,852.657-1,863.943243.444927.4941,034.23515,613.788-88.327-2,521.011994.05-949.56
Operating Expenses 33,964.37244,648.16142,099.49343,422.06140,849.07938,609.44836,977.47234,203.18339,043.6334,050.91829,967.97530,247.13829,487.48627,663.20425,471.09227,970.07625,604.908
Operating Income -16,200.386-2,465.45711,020.4126,719.62725,843.12717,775.35340,386.32129,118.07922,170.49714,374.50436,792.34927,417.09527,895.70925,106.72225,341.56112,302.97914,025.533
Operating Income Ratio -0.039-0.0050.020.0510.0510.0360.0820.0660.0510.0320.0830.0680.0740.0690.0820.0440.054
Total Other Income Expenses Net -13,802.336-3,186.632-488.851-4,486.251-2,475.14835.244-4,687.534-927.155-4,125.702-2,610.49979.08869.8838,104.939-69.679-367.2434,837.2975,305.83
Income Before Tax -30,002.722-5,652.08910,531.55822,233.37723,367.97817,810.59735,698.78628,190.92518,044.79511,764.00536,871.42928,286.97928,694.90425,037.04124,974.31617,140.27519,331.363
Income Before Tax Ratio -0.072-0.0110.020.0430.0460.0360.0730.0640.0410.0260.0840.070.0760.0690.0810.0620.074
Income Tax Expense -7,150.51-1,503.0232,078.9692,055.6495,155.5313,085.9638,392.4357,270.5894,059.672,711.9519,381.2755,680.6786,725.3894,962.1297,050.8384,551.7434,566.92
Net Income -19,085.174-4,149.0678,452.5920,177.72818,212.44814,715.91227,306.35120,920.33613,985.1259,052.05427,490.15522,606.321,969.51520,793.08517,923.47812,588.53214,764.442
Net Income Ratio -0.046-0.0080.0160.0390.0360.030.0550.0470.0320.020.0620.0560.0580.0570.0580.0450.057
EPS -769.56-167.3340.83813.62734.37593.381,1018445643651,108912886838723508595
EPS Diluted -769.56-167.3340.83813.62734.375931,1018445643651,108912886838723508595
EBITDA 12,352.23228,690.44247,311.63553,279.93253,969.36842,949.43462,498.80855,869.92343,357.47736,740.11155,934.90344,389.22337,462.81837,885.45736,357.48433,804.00339,655.748
EBITDA Ratio 0.030.0560.0880.1020.1070.0880.1270.1260.0990.0810.1270.1090.0990.1050.1180.1220.152